Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality

By HospiMedica International staff writers
Posted on 14 May 2026

Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. More...

Each hour of delayed recognition measurably decreases survival, yet timely diagnosis is challenging across busy inpatient settings. Hospitals therefore need earlier, reliable alerts that surface risk before clinicians already suspect infection. A newly cleared system now offers pre-suspicion detection of sepsis and earlier notification, with evidence of reduced mortality in U.S. hospitals.

The Targeted Real-Time Early Warning System, developed by Johns Hopkins University (Baltimore, MD, USA) researchers and commercialized by Bayesian Health, has received U.S. Food and Drug Administration (FDA) clearance for clinical use, making it one of the first AI-based medical tools to secure this regulatory clearance. Already deployed across dozens of hospitals, the system has been associated with reduced sepsis mortality. It is designed to address one of the leading causes of in-hospital death, a condition that claims more than 250,000 lives annually.

The technology integrates electronic health records with advanced clinical AI to provide “pre-suspicion” screening, aiming to surface risk before clinicians already suspect sepsis. In practice, the system has helped physicians identify cases nearly two to 48 hours earlier than traditional methods and can detect sepsis hours faster than doctors. By adding lead time, the platform is designed to prompt earlier clinical action when symptoms may still be nonspecific, such as fever or confusion.

Regulatory progress for the system has included Breakthrough Designation in 2023, under which it was deployed at several health systems including Cleveland Clinic, MemorialCare in California, and the University of Rochester School of Medicine. In those settings, it significantly reduced in-hospital mortality, morbidity, and length of stay for patients with sepsis. Across broader use in the United States, sepsis mortality rates declined by 18%. FDA clearance also opens the door for hospitals using the system to receive Medicare and Medicaid reimbursement under the New Technology Add-on Payment program.

“Pre-suspicion screening is what creates lead time, and lead time is what changes outcomes in sepsis. Once a clinician already suspects sepsis, the clock has been running—often for hours or even days,” said Suchi Saria, a Johns Hopkins professor and director of the AI & Healthcare Lab.

“It gives physicians an additional set of eyes and ears and could genuinely help save lives. This is a significant milestone for Johns Hopkins and Dr. Saria's team,” said Albert Wu, a Johns Hopkins expert in patient safety and a co-investigator on the work.

Related Links
Johns Hopkins University
Bayesian Health


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Syringe Pump
SP50 Series
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.